Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Evolus's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $5.5 Mil. Evolus's Total Assets for the quarter that ended in Dec. 2024 was $232.6 Mil.
Therefore, Evolus's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.02.
The historical rank and industry rank for Evolus's Equity-to-Asset or its related term are showing as below:
EOLS'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.5 Med: 0.06 Max: 0.49
Current: 0.02
During the past 10 years, the highest Equity to Asset Ratio of Evolus was 0.49. The lowest was -0.50. And the median was 0.06.
EOLS's Equity-to-Asset is ranked worse than 90.8% of 1033
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs EOLS: 0.02
Evolus Equity-to-Asset Historical Data
The historical data trend for Evolus's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Evolus's Equity-to-Asset
For the Drug Manufacturers - Specialty & Generic subindustry, Evolus's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolus's Equity-to-Asset Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Evolus's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Evolus's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Evolus's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolus (NAS:EOLS) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Evolus Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Evolus's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EOLS has been successfully added to your 